查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1347565

神经调节市场：2023-2028 年全球行业趋势、份额、规模、增长、机会和预测

Neuromodulation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

市场概况：

2022年全球神经调节市场规模达到67亿美元。展望未来，IMARC集团预计到2028年市场规模将达到125亿美元，2023-2028年復合年增长率（CAGR）为10.4%。

神经调节是一种通过将电剂或药剂直接输送到目标区域来调节和改变神经活动的医疗技术。它由微小电极组成，在脉衝发生器的帮助下产生电刺激，以补充患者的神经活动。电极通常放置在神经、大脑或脊髓中，而脉衝发生器则植入皮肤内。神经调节广泛用于治疗抑郁症、慢性疼痛、癫痫、震颤、偏头痛、背部衰竭综合征、帕金森病和胃轻瘫。它包括迷走神经、深部大脑、经颅磁和电刺激。它有助于监测神经活动、缓解症状并使大脑活动水平正常化。

神经调节市场趋势：

全球老年人口的增加以及阿尔茨海默病和帕金森病的患病率不断上升是推动市场增长的关键因素。神经调节广泛用于治疗膀胱过度活动症、运动能力低下、强直、震颤、行走问题、神经退行性疾病和神经系统疾病。此外，技术创新，例如提供高能量密度、可充电性和更高循环温度的锂离子电池的推出，为市场增长提供了相当大的推动力。此外，脊髓刺激（SCS）在復杂区域疼痛综合征、神经病变、神经损伤、背部手术失败综合征和蛛网膜炎等各种医疗问题中的广泛应用，对市场增长产生了积极影响。除此之外，提供低双极或单极电脉衝并用于治疗抑郁症和强迫症（OCD）的深部脑刺激（DBS）的使用越来越多，正在为市场创造积极的前景。其他因素，例如广泛的研发 (R&D) 活动和医疗保健行业的显着增长，预计将推动市场增长。

本报告回答的关键问题：

  • 迄今为止，全球神经调节市场的表现如何，未来几年将如何表现？
  • COVID-19 对全球神经调节市场有何影响？
  • 主要区域市场有哪些？
  • 基于技术的市场细分是什么？
  • 基于生物材料的市场细分是什么？
  • 基于应用程序的市场细分是什么？
  • 行业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球神经调节市场的结构如何？谁是主要参与者？
  • 行业竞争程度如何？

目录

第一章：前言

第 2 章：范围和方法

  • 研究目的
  • 利益相关者
  • 数据源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球神经调节市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按技术分類的市场

  • 内部神经调节
    • 市场走向
    • 关键环节
      • 脊髓刺激 (SCS)
      • 深部脑刺激 (DBS)
      • 迷走神经刺激 (VNS)
      • 骶神经刺激 (SNS)
      • 胃电刺激 (GES)
    • 市场预测
  • 外部神经调节
    • 市场走向
    • 关键环节
      • 经皮电神经刺激 (TENS)
      • 经颅磁刺激 (TMS)
      • 其他的
    • 市场预测

第 7 章：生物材料市场细分

  • 金属生物材料
    • 市场走向
    • 市场预测
  • 高分子生物材料
    • 市场走向
    • 市场预测
  • 陶瓷生物材料
    • 市场走向
    • 市场预测

第 8 章：按应用分類的市场细分

  • 帕金森病
    • 市场走向
    • 市场预测
  • 癫痫
    • 市场走向
    • 市场预测
  • 沮丧
    • 市场走向
    • 市场预测
  • 肌张力障碍
    • 市场走向
    • 市场预测
  • 疼痛管理
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场细分

  • 北美
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳大利亚
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉美
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Bioventus Inc.
    • Boston Scientific Corporation
    • Helius Medical Technologies
    • Integer Holdings Corporation
    • LivaNova PLC
    • Medtronic plc
    • MicroTransponder Inc.
    • Neuronetics
    • NeuroPace Inc.
    • NeuroSigma Inc.
    • Nevro Corp.
Product Code: SR112023A5722

Market Overview:

The global neuromodulation market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.5 Billion by 2028, exhibiting a growth rate (CAGR) of 10.4% during 2023-2028.

Neuromodulation is a medical technique used for the modulation and alteration of nerve activities by delivering electrical or pharmaceutical agents directly to the targeted area. It consists of tiny electrodes that generate electrical stimulation with the help of pulse generators to supplement neurological activities in the patients. The electrodes are generally placed in the nerves, brain, or spinal cord, whereas pulse generators are implanted within the skin. Neuromodulation is widely used to treat depression, chronic pain, epilepsy, tremor, migraine, failed back syndrome, Parkinson's disease, and gastroparesis. It includes the vagal nerve, deep brain, transcranial magnetic, and electrical stimulation. It assists in monitoring nerve activity, alleviating symptoms, and normalizing activity levels in the brain.

Neuromodulation Market Trends:

The rising geriatric population and the increasing prevalence of Alzheimer's and Parkinson's diseases across the globe are key factors driving the market growth. Neuromodulation is widely used to treat overactive bladder, low movement, rigidity, tremor, walking problems, neurodegenerative, and neurological disorders. Moreover, technological innovations, such as the introduction of lithium-ion (Li-ion) batteries that provide high energy density, rechargeability, and enhanced cycling temperature, are providing a considerable boost to the market growth. Additionally, the widespread utilization of spinal cord stimulation (SCS) in various medical problems, such as complex regional pain syndrome, neuropathy, nerve damage, failed-back surgery syndrome, and arachnoiditis, is positively impacting the market growth. Apart from this, the increasing usage of deep brain stimulation (DBS) that delivers low bipolar or monopolar electric impulses and is used in the treatment of depression and obsessive-compulsive disorders (OCD) is creating a positive outlook for the market. Other factors, such as extensive research and development (R&D) activities and significant growth in the healthcare industry, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global neuromodulation market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on technology, biomaterial and application.

Breakup by Technology:

Internal Neuromodulation

Spinal Cord Stimulation (SCS)

Deep Brain Stimulation (DBS)

Vagus Nerve Stimulation (VNS)

Sacral Nerve Stimulation (SNS)

Gastric Electrical Stimulation (GES)

External Neuromodulation

Transcutaneous Electrical Nerve Stimulation (TENS)

Transcranial Magnetic Stimulation (TMS)

Others

Breakup by Biomaterial:

Metallic Biomaterials

Polymeric Biomaterials

Ceramic Biomaterials

Breakup by Application:

Parkinson's Disease

Epilepsy

Depression

Dystonia

Pain Management

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bioventus Inc., Boston Scientific Corporation, Helius Medical Technologies, Integer Holdings Corporation, LivaNova PLC, Medtronic plc, MicroTransponder Inc., Neuronetics, NeuroPace Inc., NeuroSigma Inc., Nevro Corp.

Key Questions Answered in This Report:

  • How has the global neuromodulation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global neuromodulation market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the biomaterial?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global neuromodulation market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neuromodulation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Internal Neuromodulation
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Spinal Cord Stimulation (SCS)
      • 6.1.2.2 Deep Brain Stimulation (DBS)
      • 6.1.2.3 Vagus Nerve Stimulation (VNS)
      • 6.1.2.4 Sacral Nerve Stimulation (SNS)
      • 6.1.2.5 Gastric Electrical Stimulation (GES)
    • 6.1.3 Market Forecast
  • 6.2 External Neuromodulation
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
      • 6.2.2.2 Transcranial Magnetic Stimulation (TMS)
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Biomaterial

  • 7.1 Metallic Biomaterials
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymeric Biomaterials
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ceramic Biomaterials
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Parkinson's Disease
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Epilepsy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Depression
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Dystonia
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Pain Management
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bioventus Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Boston Scientific Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Helius Medical Technologies
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Integer Holdings Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 LivaNova PLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 MicroTransponder Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Neuronetics
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 NeuroPace Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 NeuroSigma Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Nevro Corp.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials

List of Figures

  • Figure 1: Global: Neuromodulation Market: Major Drivers and Challenges
  • Figure 2: Global: Neuromodulation Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Neuromodulation Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Neuromodulation Market: Breakup by Technology (in %), 2022
  • Figure 5: Global: Neuromodulation Market: Breakup by Biomaterial (in %), 2022
  • Figure 6: Global: Neuromodulation Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Neuromodulation Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Neuromodulation (Internal Neuromodulation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Neuromodulation (Internal Neuromodulation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Neuromodulation (External Neuromodulation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Neuromodulation (External Neuromodulation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Neuromodulation (Metallic Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Neuromodulation (Metallic Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Neuromodulation (Polymeric Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Neuromodulation (Polymeric Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Neuromodulation (Ceramic Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Neuromodulation (Ceramic Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Neuromodulation (Parkinson's Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Neuromodulation (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Neuromodulation (Epilepsy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Neuromodulation (Epilepsy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Neuromodulation (Depression) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Neuromodulation (Depression) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Neuromodulation (Dystonia) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Neuromodulation (Dystonia) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Neuromodulation (Pain Management) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Neuromodulation (Pain Management) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Neuromodulation (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Neuromodulation (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Neuromodulation Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Neuromodulation Industry: SWOT Analysis
  • Figure 80: Global: Neuromodulation Industry: Value Chain Analysis
  • Figure 81: Global: Neuromodulation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neuromodulation Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Neuromodulation Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 3: Global: Neuromodulation Market Forecast: Breakup by Biomaterial (in Million US$), 2023-2028
  • Table 4: Global: Neuromodulation Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Neuromodulation Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Neuromodulation Market: Competitive Structure
  • Table 7: Global: Neuromodulation Market: Key Players